Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Microscopic polyarteritis has a poor prognosis in Chinese

P K Li¹, S F Lui, F M Lai

¹Department of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin.

The Journal of Rheumatology

|July 1, 1995

Summary

Microscopic polyarteritis (MPA) in Chinese patients presents as a severe disease with poor prognosis, often involving significant lung and kidney issues. This retrospective study highlights the aggressive nature and high mortality rate of MPA in this demographic.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to "Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity" [J. Ethnopharmacol. 292 (2022) 115146].

Journal of ethnopharmacology·2025

Same author

Corrigendum to "Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity" [J. Ethnopharmacol. 292 (2022) 115146].

Journal of ethnopharmacology·2025

Same author

Management of chronic kidney disease: a Hong Kong consensus recommendation.

Hong Kong medical journal = Xianggang yi xue za zhi·2024

Same author

Next-generation sequencing for deducing donor mismatched human leukocyte antigen typing from urine of kidney transplant recipients: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2022

Same author

Modified urine typing to enhance clinical management in kidney transplant patients with unknown donor human leukocyte antigen typing: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2022

Same author

Corrigendum to "Timing of continuous renal replacement therapy in severe acute kidney injury patients with fluid overload: A retrospective cohort study" [J Crit Care. 2021 Aug; 64: 226-236].

Journal of critical care·2021

Area of Science:

Rheumatology
Internal Medicine
Immunology

Background:

Microscopic polyarteritis (MPA) is a systemic vasculitis affecting small vessels.
Understanding MPA's clinical course and outcomes in diverse populations is crucial for effective management.

Purpose of the Study:

To retrospectively analyze the clinical course and outcomes of 10 Chinese patients diagnosed with microscopic polyarteritis (MPA).
To investigate the specific manifestations and prognosis of MPA in a Chinese patient cohort.

Main Methods:

Retrospective analysis of 10 consecutive Chinese patients with MPA admitted between 1990-1993.
Assessment of clinical presentation, disease severity, treatment regimens, and survival outcomes.
Assay of serum antineutrophil cytoplasmic autoantibody (ANCA) levels, including pANCA and antimyeloperoxidase antibodies.

Related Experiment Videos

Main Results:

The study cohort had a mean age of 61 years, with equal male to female ratio.
Eighty percent of patients presented with renal impairment, and 50% required dialysis.
Pulmonary hemorrhage occurred in 70% of patients, with 60% needing ventilatory support due to hypoxic lung disease.
All patients were pANCA positive, and 80% tested positive for antimyeloperoxidase antibodies.
Treatment involved immunosuppressants (steroids, cyclophosphamide) and plasma exchange.
The mean survival was 9 months, with high mortality due to respiratory failure, infection, uremia, and stroke.
ANCA levels correlated with disease activity.

Conclusions:

MPA in Chinese patients appears to be a more severe disease with a poorer prognosis compared to other populations.
Older age and more frequent, severe pulmonary and renal manifestations may contribute to the observed poor outcomes.
This suggests potential ethnic or demographic variations in MPA presentation and severity.